Biotest Aktie


Shareholder Structure

The data shown was taken in each case from the latest announcement communicated by the shareholder.

Ordinary Shares:
Release according to § 21 Abs. 1 WpHG:
89.88%   Tiancheng (Germany) Pharmaceutical Holdings AG (acquisition company of the Creat Group Corporation)
4.99%   JO Hambro Capital Management Ltd, London, UK
Preference Shares:
100.00%   Free float